$1.8B Biotech Sale Targeted In 3 Delaware Class Suits
Attorneys for former Emisphere Technologies Inc. stockholders asked Delaware's Chancery Court to consolidate three class suits seeking damages from a $1.8 billion sale of the biotechnology company to Novo Nordisk A/S...To view the full article, register now.
Already a subscriber? Click here to view full article